Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients

RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …

Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?

IK Delattre, FS Taccone, F Jacobs, M Hites… - Expert review of anti …, 2017 - Taylor & Francis
Introduction: The pharmacokinetic/pharmacodynamic index determining β-lactam activity is
the percentage of the dosing interval (% T) during which their free serum concentration …

Therapeutic drug monitoring of β-lactam antibiotics in the ICU

S Dhaese, S Van Vooren, J Boelens… - Expert review of anti …, 2020 - Taylor & Francis
Introduction Individualizing antibiotic therapy is paramount to improve clinical outcomes
while minimizing the risk of toxicity and antimicrobial therapy. β-lactam antibiotics are …

Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno‐venous haemofiltration

DJ Selig, KS Akers, KK Chung… - British Journal of …, 2022 - Wiley Online Library
Introduction Severe burn injury involves widespread skin and tissue damage leading to
systemic inflammation, hypermetabolism and multi‐organ failure. The hypermetabolic phase …

The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose

T Tamatsukuri, M Ohbayashi, N Kohyama… - Journal of Infection and …, 2018 - Elsevier
In recent years, augmented renal clearance (ARC), in which renal function is excessively
enhanced, has been reported, and its influence on β-lactam antibiotics has been …

Population pharmacokinetics of meropenem in elderly patients: dosing simulations based on renal function

M Usman, OR Frey, G Hempel - European journal of clinical pharmacology, 2017 - Springer
Objectives The aim of this study was to evaluate different dosage regimens of meropenem in
elderly patients in relation with renal function using a population pharmacokinetic (popPK) …

Meropenem model-informed precision dosing in the treatment of critically ill patients: can we use it?

L Li, SDT Sassen, TMJ Ewoldt, A Abdulla… - Antibiotics, 2023 - mdpi.com
The number of pharmacokinetic (PK) models of meropenem is increasing. However, the
daily role of these PK models in the clinic remains unclear, especially for critically ill patients …

Does prolonged infusion time really improve the efficacy of meropenem therapy? A prospective study in critically ill patients

YC Zhao, Y Zou, YW Xiao, F Wang, BK Zhang… - Infectious Diseases and …, 2022 - Springer
Introduction Meropenem is a carbapenem antibiotic, which has demonstrated excellent
antimicrobial activity against gram-negative clinical isolates. It is also commonly used in …

Double-, single-and none-carbapenem-containing regimens for the treatment of carbapenem-resistant Enterobacterales (CRE) bloodstream infections: a retrospective …

MH Rigatto, F Ramos, A Barros… - Journal of …, 2022 - academic.oup.com
Objectives To investigate the effect of double-, single-and none-carbapenem-containing
antimicrobial regimens in the treatment of patients with carbapenem-resistant …

Pharmacokinetics of imipenem/cilastatin burn intensive care unit patients undergoing high‐dose continuous venovenous hemofiltration

BA Boucher, JQ Hudson, DM Hill… - … : The Journal of …, 2016 - Wiley Online Library
Study objective High‐dose continuous venovenous hemofiltration (CVVH) is a continuous
renal replacement therapy (CRRT) used frequently in patients with burns. However …